In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 64 for your search:
Drug:  sirolimus
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0468H1-407, NCT00129961

2.

Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: #4279, NCT00328770

4.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2003.333, NCT00133887

5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SiLVER05, EudraCT Number:, 2005-005362-36, NCT00355862

6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to under 22 at first relapse
Sponsor: NCI, Other
Protocol IDs: ASCT0431, NCI-2009-01068, CDR0000500131, COG-PBMTC-ONCO51, COG-ASCT0431, U10CA098543, NCT00382109

7.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 2 to 55
Sponsor: NCI, Other
Protocol IDs: 385, U01HL069294, BMT CTN 0402, U01 HL069294-05, NCT00406393

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 72
Sponsor: NCI, Other
Protocol IDs: 09-073, NCT00928018

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RDCRN 5702, RLD 5702, 1 U54 RR019498-01, NCT00414648

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257255, P30CA016042, UCLA-0203078, NCI-G02-2114, NCT00047073

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000557423, P30CA016042, UCLA-0604104, OSI3781s, NCT00509431

12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080078, 08-C-0078, NCT00923273

13.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: Per primary treatment protocol
Sponsor: NCI, Other
Protocol IDs: 1811.00, FHCRC-1811.00, CDR0000378004, NCT00089037

14.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: GEIS-24, 2009-017232-41, NCT01684449

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 4 to 35
Sponsor: NCI
Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979

16.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1938.00, NCI-2010-00268, P30CA015704, P01CA018029, FHCRC-1938.00, 5887, NCT00105001

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000440080, DFCI-04298, WYETH-C-0468H1-101899, NCT00126672

18.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 05-154, NCT00133367

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: 0402008, GOELAMS, PHRC, NCT00235560

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0507, CDR0000455000, P30CA006973, JHOC-J0507, JHOC-05041402, J0507, NCT00276744

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-1135.cc, NCT00353301

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0415, CDR0000549899, P30CA006973, JHOC-J0415, JHOC-04-06-16-01, J0415, NCT00499486

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: TESSTAL, NCT00490789

24.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 01089, P30CA033572, CHNMC-01089, CDR0000566376, NCT00544115

25.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 06141, P30CA033572, CHNMC-06141, CDR0000579340, NCT00589563
1    
New Search